Literature DB >> 11016284

[Hereditary hemorrhagic telangiectasia. A population-based study on prevalence and mortality among Danish HHT patients].

A D Kjeldsen1, P Vase, A Green.   

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is a dominantly inherited disease characterized by telangiectatic lesions. The disease manifestations are variable in severity. Early death due to complications has been described. We report an investigation of the prevalence and mortality of HHT in a Danish population, based on two cross-sectional surveys in combination with a long-term follow-up study. The prevalence of HHT in the county of Funen was 13.8 per 100,000 January 1. 1974 and 15.6 per 100,000 January 1. 1995. In the HHT group as a whole we found a slightly increased mortality, however among the HHT patients younger than 60 years at inclusion the mortality of HHT patients was twice the expected. The excess mortality was fully explained by severe HHT symptoms contributing to death. Future research should aim at identification of HHT patients at particular risk of developing severe complications.

Entities:  

Mesh:

Year:  2000        PMID: 11016284

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  10 in total

Review 1.  Signs and genetics of rare cancer syndromes with gastroenterological features.

Authors:  William Bruno; Giuseppe Fornarini; Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

2.  Endoglin is required in Pax3-derived cells for embryonic blood vessel formation.

Authors:  K Young; L T Krebs; E Tweedie; B Conley; M Mancini; H M Arthur; L Liaw; T Gridley; Cph Vary
Journal:  Dev Biol       Date:  2015-10-19       Impact factor: 3.582

3.  Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.

Authors:  Gita Jørgensen; Bibi Lange; Jens Højberg Wanscher; Anette Drøhse Kjeldsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-26       Impact factor: 2.503

Review 4.  Diagnostic imaging in the study of visceral involvement of hereditary haemorrhagic telangiectasia.

Authors:  M Memeo; A Scardapane; R De Blasi; C Sabbà; A Carella; G Angelelli
Journal:  Radiol Med       Date:  2008-05-13       Impact factor: 3.469

5.  Restless Leg Syndrome Is Underdiagnosed in Hereditary Hemorrhagic Telangiectasia-Results of an Online Survey.

Authors:  Freya Droege; Andreas Stang; Kruthika Thangavelu; Carolin Lueb; Stephan Lang; Michael Xydakis; Urban Geisthoff
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

6.  BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses.

Authors:  Kira Young; Eric Tweedie; Barbara Conley; Jacquelyn Ames; MaryLynn FitzSimons; Peter Brooks; Lucy Liaw; Calvin P H Vary
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

7.  Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia.

Authors:  M M Serra; C H Besada; A Cabana Cal; A Saenz; C V Stefani; D Bauso; A B Golimstok; J C Bandi; D H Giunta; C M Elizondo
Journal:  Orphanet J Rare Dis       Date:  2017-05-18       Impact factor: 4.123

Review 8.  Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.

Authors:  Athena Kritharis; Hanny Al-Samkari; David J Kuter
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

9.  A case report of unexplained jejunal telangiectasia complicated with bleeding.

Authors:  Wen-Jun Zhang; You-Shan Huang; Zheng-Ming Zhu; Hong-Liang Luo
Journal:  Int J Surg Case Rep       Date:  2020-02-06

10.  An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.

Authors:  Hanny Al-Samkari; Raj S Kasthuri; Joseph G Parambil; Hasan A Albitar; Yahya A Almodallal; Carolina Vázquez; Marcelo M Serra; Sophie Dupuis-Girod; Craig B Wilsen; Justin P McWilliams; Evan H Fountain; James R Gossage; Clifford R Weiss; Muhammad A Latif; Assaf Issachar; Meir Mei-Zahav; Mary E Meek; Miles Conrad; Josanna Rodriguez-Lopez; David J Kuter; Vivek N Iyer
Journal:  Haematologica       Date:  2021-08-01       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.